Challenges and Future Prospects of Antibacterial Therapy

Dear Colleagues,

Widespread antibiotic resistance has become one of the most serious global health threats in recent years and is much worse after COVID-19. This phenomenon has increased both mortality and morbidity as a consequence of treatment failures and its effect on healthcare costs. The misuse and overuse of antibiotics in human therapies, as well as for other areas, has resulted in the rapid emergence of multidrug-resistant (MDR) pathogens. However, new developments of novel therapeutics against MDR bacteria are still challenging. In this topic, we aim to collect studies on the most recent advances in the development of novel biocompatible antimicrobials and strategies against emerging MDR pathogens concerning design, fabrication, biocompatibility, and applications. Manuscripts will be accepted either in the form of research or review articles for all areas of antibiotics or antimicrobial materials.

Prof. Dr. Kwang-sun Kim
Dr. Zehra Edis
Topic Editors